The volume measurement, or hct blood test, is the proportion of blood that the red blood cells take up. Hemoglobin, on the other hand, is a density or concentration measurement and is expressed in grams per liter or deciliter. (Hemoglobin is, if you will recall from your high school biology, the iron-based protein that transports oxygen.) RBC is a simple count and is usually expressed as the number of million red blood cells that you have per microliter. Usually, hematocrit is three times the amount of hemoglobin.

Testosterone replacement therapy (TRT) increases hematocrit in most men.  Read more about how to decrease hematocrit.

NOTE: Hematocrit is also part of the CBC panel, so there is no need to order separately if your order already includes CBC.

D-Dimer is one of the by-products that can be measured after the fibrinolytic system is turned on. Fibrinolytic activation and intravascular thrombosis can be measured by the amount of D-Dimer in the blood. D-Dimer is especially helpful when ruling out venous thromboembolism in people who are at high risk.

The pre-op (surgery) blood test includes the three test panels (CBC, CMP, and Prothrombin Time Test) most commonly ordered before a person has surgery. Pre-operative testing is usually done during the few days before the surgery. This panel lets your surgeon know what to be aware of in case of complications during surgery.

This test includes prothrombin time plus INR and it measures how long it takes your blood to clot. It’s used to monitor the effects of the medication warfarin, and can help identify possible hereditary and clotting disorders. This test does not require fasting. Prothrombin Time (PT) is a blood test used in the evaluation of the extrinsic coagulation system; aid in screening for congenital and acquired deficiencies of factors II, V, VII, X, and fibrinogen. This test is used clinically for the therapeutic monitoring of warfarin (Coumadin®) anticoagulant therapy.

The Cardio IQ® Report provides an in-depth assessment of cardiovascular risks to help physicians recommend the ideal individualized treatment option for patient to minimize cardiovascular disease.

The report is simple, yet comprehensive. It is color-coded to display progressive risk values versus goal using “optimal,” “moderate,” and “high-risk” categories and grouped by functional categories.

Cardio IQ Advanced Lipid Panel The Cardio IQ Advanced Lipid Panel includes:Total Cholesterol, Triglycerides, HDL, LDL and Cholesterol/HDL ratio, LDL Particle Number, LDL Peak Size, LDL Pattern, HDL Large, LDL Small, LDL Medium, Apolipoprotein B, Lipoprotein (a). Fasting is not required prior to collection of a lipid panel. Results for this test take 2 weeks to receive.

A complete blood count CBC with differential test panel measures several components of your blood including:Red blood cells, which carry oxygen, White blood cells, which fight infection, Hemoglobin, the oxygen-carrying protein in red blood cells, Hematocrit, the proportion of red blood cells to the fluid component in your blood (which correlated with blood thickness), and Platelets, which help with blood clotting. This is also called Complete Blood Count (CBC) with Differential and Platelets Blood Test

Lipoprotein (a) has been called a powerful predictor of premature atherosclerotic vascular disease. As an independent risk factor for premature coronary artery disease, excess Lp(a) concentrations are associated with an increased risk of cardiac death in patients with acute coronary syndromes and with restenosis after angioplasty (PTCA) and coronary bypass procedures. In general, concentrations greater than or equal to 75 nmol/L of Lp(a) in serum are associated with a two- to sixfold increase in risk, depending on the presence of other risk factors.

Elevated levels of homocysteine in the blood, known as hyperhomocysteinemia, have been linked to an increased risk of cardiovascular disease, including heart attack and stroke. High homocysteine levels may also be associated with an increased risk of certain other health conditions, such as osteoporosis and pregnancy complications.

Quest Diagnostics test code 17911 is for a DNA mutation analysis of Methylenetetrahydrofolate Reductase (MTHFR). The test determines if a patient has one, two, or no copies of either of the two mutations in the MTHFR gene, C677T and A1298C.

Changes in the methylenetetrahydrofolate reductase gene can lead to certain health conditions. One of them is hyperhomocysteinemia (high blood levels of homocysteine), which is a risk factor for cerebrovascular disease, cerebral vein thrombosis, coronary artery disease, myocardial infarction, and venous thrombosis. At least 40 mutations in the MTHFR gene have been identified in people with homocystinuria, a disorder in which the body is unable to process certain amino acids properly.